Free Trial

Evolent Health (EVH) News Today

Evolent Health logo
$10.08 +0.40 (+4.13%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$9.88 -0.20 (-1.99%)
As of 04/2/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Evolent Health, Inc. stock logo
Raymond James Financial Inc. Invests $2.54 Million in Evolent Health, Inc. (NYSE:EVH)
Raymond James Financial Inc. acquired a new position in Evolent Health, Inc. (NYSE:EVH - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 225,995 shares of the technology company's stock, v
Evolent Health, Inc. stock logo
Quantbot Technologies LP Buys Shares of 120,056 Evolent Health, Inc. (NYSE:EVH)
Quantbot Technologies LP purchased a new position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 120,056 shares of the technology comp
Evolent Health, Inc. stock logo
Semanteon Capital Management LP Makes New $745,000 Investment in Evolent Health, Inc. (NYSE:EVH)
Semanteon Capital Management LP acquired a new position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 66,230 shares of the technology company
Evolent Health, Inc. stock logo
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 70,617 Evolent Health, Inc. (NYSE:EVH)
Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 70,617 shares of the technology company's stock, valued at approximately $794,000. C
Evolent Health, Inc. stock logo
Boston Partners Boosts Position in Evolent Health, Inc. (NYSE:EVH)
Boston Partners grew its holdings in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 92.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,444,006 shares of the technology company's stock after buying an additional 1,171,304 shares duri
Evolent Health, Inc. stock logo
Evolent Health, Inc. (NYSE:EVH) Shares Purchased by Royce & Associates LP
Royce & Associates LP grew its holdings in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 130.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 576,200 shares of the technology company's stock
Evolent Health, Inc. stock logo
William Blair Investment Management LLC Reduces Holdings in Evolent Health, Inc. (NYSE:EVH)
William Blair Investment Management LLC decreased its position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 3.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,781,131 shares of the technology company'
Evolent Health, Inc. stock logo
Ironwood Investment Management LLC Purchases 27,927 Shares of Evolent Health, Inc. (NYSE:EVH)
Ironwood Investment Management LLC raised its position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) by 115.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 52,072 shares of the
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Price Target Cut to $12.00 by Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. lowered their price target on shares of Evolent Health from $13.00 to $12.00 and set an "overweight" rating for the company in a report on Monday.
Evolent Health, Inc. stock logo
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of "Buy" from Analysts
Shares of Evolent Health, Inc. (NYSE:EVH - Get Free Report) have been assigned an average recommendation of "Buy" from the fourteen research firms that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, twelve have assigned a bu
Evolent Health price target lowered to $12 from $13 at JPMorgan
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Shares Gap Up After Insider Buying Activity
Evolent Health (NYSE:EVH) Shares Gap Up After Insider Buying Activity
Evolent Health, Inc. stock logo
Evolent Health, Inc. (NYSE:EVH) Director Acquires $25,517.55 in Stock
Evolent Health, Inc. (NYSE:EVH - Get Free Report) Director Diane Holder purchased 2,735 shares of the firm's stock in a transaction on Thursday, March 6th. The shares were acquired at an average cost of $9.33 per share, for a total transaction of $25,517.55. Following the completion of the purchase, the director now directly owns 70,584 shares of the company's stock, valued at approximately $658,548.72. This represents a 4.03 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Evolent Health, Inc. stock logo
Daniel Joseph Mccarthy Acquires 11,040 Shares of Evolent Health, Inc. (NYSE:EVH) Stock
Evolent Health, Inc. (NYSE:EVH - Get Free Report) President Daniel Joseph Mccarthy purchased 11,040 shares of the business's stock in a transaction on Thursday, March 6th. The shares were acquired at an average price of $9.01 per share, for a total transaction of $99,470.40. Following the completion of the acquisition, the president now directly owns 389,004 shares in the company, valued at approximately $3,504,926.04. This represents a 2.92 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
Evolent Health, Inc. stock logo
Evolent Health, Inc. (NYSE:EVH) CEO Seth Blackley Acquires 55,225 Shares
Evolent Health, Inc. (NYSE:EVH - Get Free Report) CEO Seth Blackley acquired 55,225 shares of the firm's stock in a transaction on Thursday, March 6th. The shares were bought at an average cost of $9.01 per share, with a total value of $497,577.25. Following the completion of the transaction, the chief executive officer now directly owns 762,217 shares in the company, valued at $6,867,575.17. This trade represents a 7.81 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Evolent Health, Inc. stock logo
Edgestream Partners L.P. Takes $2 Million Position in Evolent Health, Inc. (NYSE:EVH)
Edgestream Partners L.P. purchased a new stake in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 177,372 shares of the technology company's stock, valued at appro
Evolent Health, Inc. stock logo
152,251 Shares in Evolent Health, Inc. (NYSE:EVH) Bought by Prescott Group Capital Management L.L.C.
Prescott Group Capital Management L.L.C. bought a new stake in Evolent Health, Inc. (NYSE:EVH - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 152,251 shares of the technology company's stock, valued at appr
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Stock Price Up 4.9% Following Insider Buying Activity
Evolent Health (NYSE:EVH) Trading Up 4.9% on Insider Buying Activity
Evolent Health, Inc. stock logo
Insider Buying: Evolent Health, Inc. (NYSE:EVH) Director Acquires 5,000 Shares of Stock
Evolent Health, Inc. (NYSE:EVH - Get Free Report) Director Brendan B. Springstubb purchased 5,000 shares of the firm's stock in a transaction that occurred on Tuesday, March 4th. The stock was purchased at an average price of $8.75 per share, with a total value of $43,750.00. Following the completion of the purchase, the director now directly owns 11,842 shares of the company's stock, valued at approximately $103,617.50. This represents a 73.08 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Hits New 52-Week Low - Time to Sell?
Evolent Health (NYSE:EVH) Hits New 52-Week Low - What's Next?
Evolent Health, Inc. stock logo
Levin Capital Strategies L.P. Invests $664,000 in Evolent Health, Inc. (NYSE:EVH)
Levin Capital Strategies L.P. acquired a new position in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 59,000 shares of the technology company's stock, valued at approximately $6
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Reaches New 52-Week Low - Here's What Happened
Evolent Health (NYSE:EVH) Hits New 12-Month Low - Should You Sell?
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Trading Down 5.5% - Here's Why
Evolent Health (NYSE:EVH) Trading Down 5.5% - Here's What Happened
Evolent Health price target raised to $13 from $12 at Citizens JMP
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Receives "Overweight" Rating from Piper Sandler
Piper Sandler reaffirmed an "overweight" rating and issued a $16.00 target price (down from $17.00) on shares of Evolent Health in a research report on Friday.
Evolent Health Full Year 2024 Earnings: EPS Beats Expectations
Evolent Health, Inc. stock logo
Needham & Company LLC Reaffirms Buy Rating for Evolent Health (NYSE:EVH)
Needham & Company LLC reaffirmed a "buy" rating and issued a $15.00 target price on shares of Evolent Health in a report on Friday.
Evolent Health, Inc. stock logo
Hussman Strategic Advisors Inc. Takes $709,000 Position in Evolent Health, Inc. (NYSE:EVH)
Hussman Strategic Advisors Inc. acquired a new stake in shares of Evolent Health, Inc. (NYSE:EVH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 63,000 shares of the
Evolent Health price target lowered to $16 from $17 at Piper Sandler
Oppenheimer Remains a Buy on Evolent Health (EVH)
JMP Securities Keeps Their Buy Rating on Evolent Health (EVH)
Evolent Health, Inc. stock logo
Evolent Health (NYSE:EVH) Issues Earnings Results
Evolent Health (NYSE:EVH - Get Free Report) issued its quarterly earnings data on Thursday. The technology company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.35). Evolent Health had a negative net margin of 2.93% and a positive return on equity of 6.30%.
KeyBanc Sticks to Their Buy Rating for Evolent Health (EVH)
Evolent Health reports Q4 EPS (2c), consensus 1c
Evolent Health sees Q1 revenue $440M-$447M, consensus $592.1M
Remove Ads
Get Evolent Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.

EVH Media Mentions By Week

EVH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EVH
News Sentiment

0.51

0.60

Average
Computer and Technology
News Sentiment

EVH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EVH Articles
This Week

3

5

EVH Articles
Average Week

Remove Ads
Get Evolent Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:EVH) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners